Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation.

Precision oncology uses information on the patient's own tumor to create personalized therapies, such as RNA cancer vaccines. These therapies train a patient's own immune system to attack cancer.

Designing RNA sequences that are stable and efficiently translated is complex. AI-driven tools are unlocking new possibilities, enabling optimized RNA design to accelerate therapeutic development.

Eclipsebio is proud to announce their sponsorship of the 2025 Gordon Research Conference on Decoding Microproteins Across Evolution and Disease in Barcelona.

mRNA therapeutics are fundamentally transforming the way we approach modern medicine. In this eBlog we review how mRNA is providing rapid and scalable solutions.